Cutler Group LP Karyopharm Therapeutics Inc. Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$2.48 - $5.93 $10,912 - $26,092	4,400 Added 1050.12%	4,819 $16,000
Q3 2022 Oct 25, 2022	SELL	$4.08 - $5.82 $3,264 - $4,656	-800 Reduced 65.63%	419 $2,000
Q2 2022 Aug 04, 2022	BUY	$4.15 - $8.37 $5,058 - $10,203	1,219 New	1,219 $5,000
Q2 2020 Jul 22, 2020	SELL	$16.6 - $25.25 $26,560 - $40,400	-1,600 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$9.23 - $19.67 $14,768 - $31,472	1,600 New	1,600 $30,000
Q4 2017 Jan 17, 2018	SELL	$9.15 - $11.99 $155 - $203	-17 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$8.15 - $11.16 $138 - $189	17	17 $0

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $64.6M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.